The last decade has seen an increase in the use of illicit drugs and alcohol in the community including an increase in the use of these agents by women in the reproductive age group. With this in mind, health-care workers need to avoid being complacent in caringfor these women -they are a high-risk obstetric population with a significant incidence of medical, obstetric and paediatric complications. This paper concentrates on the antenatal and intrapartum problems, and outlines their management. An overview of the problem is presented as well as an illustrative case report.
BACKGROUND
A recent study at the Royal Women's Hospital in Melbourne (1988) (1989) used anonymous urinary drug screening by thin-layer chromatography of a routine antenatal population. A one percent incidence of illicit use of narcotics or amphetamines was found. The same incidence of otherwise undetected drug abuse was found at the Royal Women's Hospital, Crown Street, Sydney in the early 1980s 2 . The incidence of tranquilliser (soft drugs) abuse in pregnancy has been reported at three to five percent. One large United States study of middle class pregnant women revealed a 25 percent incidence of sedative use at some time during pregnancy. 2 Three percent of adult females are alcoholics or problem drinkers. The prospect of pregnancy does not appear to substantially change drinking behaviour with two to five percent of pregnant women drinking the equivalent of 60 g of absolute alcohol per day or binge drinking. 3 To manage the numerous medical, obstetric and paediatric problems arising in the addicted parturient and her neonate, speciality clinics have been developed in most large obstetric centres.
The aim of these clinics is to reduce the maternal and perinatal· morbidity and mortality associated with these high-risk pregnancies. This reduction is achieved by ensuring early antenatal attendance, regular and frequent antenatal visits, the early diagnosis and management of problems, and aid with drug rehabilitation, especially the use of methadone replacement in narcotic users. [4] [5] [6] [7] Besides the numerous medical and obstetric complications these women frequently have housing, legal and financial problems. Psychiatric disorders, especially depression, and low selfesteem are common. 8 As amenorrhoea is a common occurrence with narcotic abuse especially, and as symptoms of pregnancy may be blamed on drug withdrawal, late presentation for antenatal care is common. A mistrust of medical practitioners and institutions may also be a factor. Overall, these patients commonly neglect antenatal care.
Case Report
A 28-year-old woman with a twelve-year history of heroin and benzodiazepine abuse presented for the first time for antenatal care at 26 weeks' gestation. The pregnancy came to her notice only after fetal movements were feIt.
Her past medical history revealed hepatitis B, subacute bacterial endocarditis and mUltiple trauma following a motor vehicle accident. Obstetrically she had a past history of two secondtrimester therapeutic abortions.
Liver function tests were abnormal in keeping with previous hepatitis. She had a mixed iron-SYMPOSIUM -OBSTETRIC ANAESTHESIA folate deficiency anaemia. Cervical swabs were positive for Chlamydia. A HIV screen was negative. A urinary drug screen revealed morphine (a metabolite of heroin), and benzodiazepines.
Stabilisation on a methadone dose of 40 mg occurred in hospital.
She was admitted to labour ward in premature labour at 34 weeks' gestation. After a precipitate two-hour labour she had a normal vaginal delivery of a male infant weighing 850 g with Apgar scores of 10 at 1 and 5 minutes. The neonate was severely growth-retarded. The main perinatal problems were mild respiratory distress not requiring ventilation, neonatal drug withdrawal requiring treatment with phenobarbitone for four weeks and hyperbilirubinaemia requiring phototherapy.
DISCUSSION

Antenatal course and complications:
Drug dependency in pregnancy is a frequently missed diagnosis. Patients often do not volunteer information due to their distrust of doctors. These women have often had bad experiences in the past with judgemental medical practitioners.
A high index of suspicion is required. The diagnosis should be considered in women with pupillary constriction, trackmarks, thrombotic veins, localised oedema over veins, subcutaneous abscesses or scarring, tattoos, lymphadenopathy, hepatomegaly, bizarre behaviour, a history of drugassociated diseases, or poor attendance for antenatal care. The diagnosis may be retrospective when a neonate shows symptoms or signs of drug withdrawal. If the diagnosis is suspected a urinary drug screen should be obtained.
Polydrug use is common. For example, alcohol or minor tranquiIizers have synergistic mood-altering effects when used with narcotics. Similarly women withdrawing from amphetamines often selfmedicate with benzodiazepines to treat the agitation associated with withdrawal. The incidence of spontaneous abortion is not increased with drug abuse in pregnancy. Similarly the incidence of fetal abnormalities has not been shown to be increased with the use of heroin, methadone, amphetamines, barbiturates, benzodiazepines or cannabis.
Alcohol abuse can be associated with a group of fetal abnormalities making up the fetal-alcohol syndrome, with an incidence of 2 per 1000 livebirths. The syndrome is seen in women drinking more than 90 g or more of absolute alcohol per day or binge drinkers. 3 Cocaine abuse is associated with genito-urinary tract abnormalities and vasoconstriction leading to gut atresias, loss of digits and cerebral infarction in utero ..
Up to fifty per cent of women who abuse illicit drugs in pregnancy have at least one significant medical or surgical complication. These include anaemia (especially due to folate deficiency), acute and chronic hepatitis, sexually transmitted diseases, septicaemia, bacterial endocarditis, thrombophlebitis, pneumonia, urinary tract infections, AIDS and psychiatric illness. 1, 3 Up to fifteen per cent of drug-abusing pregnant women have evidence of severe malnutrition. 3 The major two obstetric complications are intrauterine growth retardation and premature labour. Recurrent episodes of maternal drug withdrawal may lead to increased uterine muscle tone and therefore a reduction in placental blood flow.
Seventy-five per cent of women attending the clinic require at least one antenatal admission for a significant medical or obstetric complication.
Drug abuse associated pregnancies need therefore to be managed as high-risk with early intervention and treatment of medical, obstetric and social problems.
The key to adequate antenatal care is a team approach by obstetrician, paediatrician, midwife and social worker, preferably in a specialised clinic.
Drug rehabilitation should occur in association with a drug treatment agency. Rapid drug withdrawal is to be avoided as in the first trimester it may be associated with spontaneous abortion and in the third trimester it may lead to fetal distress or even fetal death in utero.
Women using non-narcotic drugs should be detoxified slowly in the second trimester. Amphetamines and cocaine are potently addictive and detoxification is difficult.
Heroin-dependent women are best managed by methadone replacement. Slow reduction to a maintenance dose (usually 15 to 25 mg) can occur in the second trimester. The advantages of methadone compared with heroin use include a constant drug milieu for the fetus rather than intermittent periods of withdrawal, drug purity, known dosage, reduced incidence of prematurity and growth retardation. However the antenatal advantages of methadone are at the expense of neonatal disadvantages especially the often increased severity of neonatal drug wihdrawal.
Management in labour
Late presentation in labour is common as early signs may be confused with drug withdrawal. Many women self-medicate to control the labour pain or the supposed drug withdrawal. A urinary drug screen should be taken on all drug-dependent women when they present in labour. 9 If on admission to labour ward the patient is withdrawing, she should be given her usual methadone dose. If this is not available a shortacting narcotic such as pethidine can be used. Women not already on a methadone program can be given 20 mg of methadone as a starting dose.
An intravenous line should be inserted electively to avoid delays in treatment as access may be difficult. A central line may be needed.
The management of pain relief in labour is the same as for non-drug-dependent women. Pethidine may be used; methadone is not adequate for analgesia. Phenergan can be used in combination with pethidine to reduce apprehension and anxiety.
Care should be taken in using drugs which are hepatotoxic or largely detoxified in the liver as many drug-dependent women have adnormalliver function tests. Naloxone is contraindicated except in life-threatening cases as it may precipitate maternal drug withdrawal, fetal distress or even fetal death in utero. Regional anaesthesia is commonly used and is especially useful in women who continue to use large amounts of heroin or in women on methadone doses of greater than 50 mg.
The average duration of labour is the same in drug-dependent women when compared to controls. There is no increase in the third stage of labour complications, including post partum haemorrhage.
RECOMMENDA nONS 1. Due to the complex problems associated with drug abuse in pregnancy, a speciality clinic utilising a team approach to care is essential. 2. A high index of suspicion is required to diagnose drug dependency in pregnancy. Where doubt exists a urinary drug screen should be taken. 3. Medical, surgical and obstetric complications are common. Early intervention is necessary, and hospital admission is frequently required. 4. Drug rehabilitation should occur in co-operation with a treatment agency. Methadone is the preferred treatment of narcotic abuse in pregnancy. If detoxification is to be carried out it should be in the second trimester. 5. The management of pain relief in labour is the same as for non-drug-dependent women. Regional anaesthesia is frequently required.
